These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7994793)

  • 1. Single instillation of hydroxypropylcellulose-doxorubicin as treatment for superficial bladder carcinoma.
    Ueda K; Sakagami H; Masui Y; Okamura T
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S81-3. PubMed ID: 7994793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-shot intravesical instillation of the mucous adhesive anticancer agent hydroxypropylcellulose-doxorubicin for the treatment of superficial bladder carcinoma is sufficient to determine antitumor effects.
    Ueda K; Sakagami H; Masui Y; Okamura T; Ohtaguro K
    Eur Urol; 1993; 24(1):62-5. PubMed ID: 8365442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the retention of the mucous-membrane-adhesive anticancer agent hydroxypropylcellulose doxorubicin.
    Ueda K; Sakagami H; Ohtaguro K; Masui Y
    Eur Urol; 1992; 21(3):250-2. PubMed ID: 1499635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer.
    Rolevich AI; Zhegalik AG; Mokhort AA; Minich AA; Vasilevich VY; Polyakov SL; Krasny SA; Sukonko OG
    World J Urol; 2017 May; 35(5):745-752. PubMed ID: 27604374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of superficial transitional cell bladder carcinoma. Long-term results of trial comparing transurethral resection alone and adjuvant chemotherapy with Doxorubicin].
    Milonas D; Mickevicius J; Mickevicius R; Motiejūnas A; Sukys D; Gudinaviciene I
    Medicina (Kaunas); 2002; 38 Suppl 1():79-83. PubMed ID: 12556642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative doxorubicin instillation in recurrent superficial bladder cancer.
    Kubota Y; Noguchi S; Shuin T; Moriyama M; Hosaka M; Satomi Y; Furuhata A; Kondo I; Sakuramoto T; Yao M
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S56-9. PubMed ID: 3664944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined treatment in patients with carcinoma in situ of the urinary bladder using intravesical pirarubicin, irradiation and hyperthermia].
    Takechi T; Kawamura M; Nakagawa H; Inatsuki S; Akiyama K; Yano M; Sumiyoshi Y; Mandai K; Moriwaki S; Kataoka M
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2724-7. PubMed ID: 2277223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical chemoresection with 4'-epi-doxorubicin in patients with superficial bladder tumors.
    Calais da Silva F; Denis L; Bono A; Bollack C; Bouffioux C
    Eur Urol; 1988; 14(3):207-9. PubMed ID: 3289935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of superficial bladder carcinoma with intravesical HPC-adriamycin and verapamil].
    Ueda K
    Nihon Hinyokika Gakkai Zasshi; 1990 Mar; 81(3):461-4. PubMed ID: 2359224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of cytostatic intravesical instillation in patients with superficial bladder carcinoma. Is short-term, intensive instillation better than maintenance therapy?
    Schwaibold H; Pichlmeier U; Klingenberger HJ; Huland H
    Eur Urol; 1997; 31(2):153-9. PubMed ID: 9076457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the preoperative intravesical instillation of doxorubicin and the oral administration of 5-fluorouracil in preventing recurrence after a transurethral resection of superficial bladder cancer. Kyushu University Urological Oncology Group.
    Naito S; Iguchi A; Sagiyama K; Ariyoshi A; Osada Y; Omoto T; Kuriya N; Kumazawa J
    Int J Urol; 1997 Jul; 4(4):352-7. PubMed ID: 9256323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F; Schuster F
    Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.
    Colombo R; Da Pozzo LF; Lev A; Salonia A; Rigatti P; Leib Z; Servadio C; Caldarera E; Pavone-Macaluso M
    J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma.
    Garnick MB; Schade D; Israel M; Maxwell B; Richie JP
    J Urol; 1984 Jan; 131(1):43-6. PubMed ID: 6690745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical therapy with adriamycin plus verapamil in patients with superficial bladder cancer: a pilot study.
    Naito S; Kimiya K; Ueda T; Kumazawa J; Omoto T; Osada Y; Iguchi A; Ariyoshi A; Sagiyama K
    Urol Int; 1992; 48(3):270-3. PubMed ID: 1589915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group.
    Ueda T; Naito S; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S31-6. PubMed ID: 1394813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term versus short-term doxorubicin hydrochloride instillation after transurethral resection of superficial bladder cancer.
    Flamm J
    Eur Urol; 1990; 17(2):119-24. PubMed ID: 2178939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder.
    Serretta V; Piazza S; Pavone C; Piazza B; Pavone-Macaluso M
    Urology; 1996 May; 47(5):647-51. PubMed ID: 8650860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.
    Paroni R; Salonia A; Lev A; Da Pozzo LF; Cighetti G; Montorsi F; Rigatti P; Colombo R
    Br J Clin Pharmacol; 2001 Sep; 52(3):273-8. PubMed ID: 11560559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.